Abstract:Individuals actively infected with respiratory viruses, such as influenza A virus (IAV), respiratory syncytial virus (RSV), and coronaviruses, transmit by shedding droplets containing live virus while coughing, sneezing, or talking. Respiratory viruses subsequently enter the airways of a host either by coming in direct contact with aerosolized droplets or by an interaction with fomites [1]. The majority of respiratory virus infections are contained to the upper airways and self-limiting; however, lower respiratory tract infections (LRTIs) are a significant cause of morbidity and mortality, especially in children and the elderly [2,3]. When infiltration into the lower airways occurs, infectious viral particles encounter lung resident alveolar macrophages (AMφ). AMφ are self-renewing fetal-derived sentinel cells present in the airways that are tethered to the lung epithelium through αvβ6 integrin-latent TGF-β binding [4,5]. Upon direct interaction with viral particles, pro-inflammatory cytokines, or pattern/danger-associated molecular patterns (PAMPs/DAMPs), AMφ detach from the respiratory epithelium resulting in the induction of increased effector functions and phagocytosis as well as the up-regulation of type I interferons (IFN), chemokines, and pro-inflammatory cytokines [6–8]. AMφ express a myriad of pattern recognition receptors, including multiple toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) that sense viral genetic material and proteins driving NF-κB activation, type I IFN production, and the release of pro-inflammatory cytokines [9]. Early during infection, virus utilization of TLRs as attachment receptors, such as TLR4, as well as other molecules with signaling capacity have been shown to drive innate activation [10]. Intracellular sensors responding to the viral genome including MDA5/RIG-I and TLRs 3, 7, and 8, also mediate activation signals [11]. This early "danger alarm" response by AMφ is critical to the initiation of the innate immune response within the lung resulting in increased neutrophil and mononuclear cell infiltration and the induction of the antiviral IFN response pathways [6–8]. In vivo depletion of AMφ resulted in significantly increased disease and mortality in IAV-infected mice [7]. AMφ activation and pro-inflammatory cytokine production played a critical role in the activation of the immune system and RSV infection. Clodronate liposome depletion of AMφ prior to infection significantly reduced RSV-induced TNF, IL-6, IFNα, and chemokine production in the lung [8]. AMφ-depleted mice also exhibited significantly increased RSV-induced airway hyperreactivity as compared to controls [12]. Interestingly, AMφ significantly contributed to the induction of severe disease and immunopathology following human metapneumovirus (hMPV) infection. AMφ depletion ameliorated hMPV-induced disease and reduced lung inflammation suggesting excess pro-inflammatory responses contribute to disease [12]. Additionally, AMφ are essential to the resolution of inflammation and return to a homeostatic state without which severe immunopathology and lung damage can occur [13]. This highlights the multifaceted ability of AMφ to protect the respiratory epithelium and initiate the innate immune response while also playing an essential role in tissue damage control.

Human rhinovirus 16 induces an ICAM-1-PKR-ATF2 axis to modulate macrophage functions

ARL5b inhibits human rhinovirus 16 propagation and impairs macrophage-mediated bacterial clearance

Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection

Rhinovirus stimulated IFN-α production: how important are plasmacytoid DCs, monocytes and endosomal pH?

Transcriptomics of rhinovirus persistence reveals sustained expression of RIG-I and interferon-stimulated genes in nasal epithelial cells in vitro

Rhinovirus-induced IFNβ expression is NFκB-dependent and regulated by the macrophage microenvironment

The Role of Interleukin-1 and Interleukin-18 in Pro-Inflammatory and Anti-Viral Responses to Rhinovirus in Primary Bronchial Epithelial Cells

Response to Rhinovirus Infection by Human Airway Epithelial Cells and Peripheral Blood Mononuclear Cells in an In Vitro Two-Chamber Tissue Culture System

Rhinovirus infection induces distinct transcriptome profiles in polarized human macrophages

Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses

Characterising the mechanism of airway smooth muscle β2 adrenoceptor desensitization by rhinovirus infected bronchial epithelial cells

Rhinoviral infection and asthma: the detection and management of rhinoviruses by airway epithelial cells

Rhinovirus infection of the airway epithelium enhances mast cell immune responses via epithelial-derived interferons

Mechanism of Rhinovirus Immunity and Asthma

Human lung vascular endothelium may limit viral replication and recover in time upon the infection with rhinovirus HRV16

Rhinovirus-16 Induced Release of IP-10 and IL-8 Is Augmented by Th2 Cytokines in a Pediatric Bronchial Epithelial Cell Model

Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium

Respiratory viruses and the inflammasome: The double-edged sword of inflammation

Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection

A role for anti-IL33 strategies to limit the epithelial rhinoviral response?

Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD